Market Place
Sourcing Support
All News #Library
Biotech
Citryll Secures EU Patent for Lead Drug Candidate CIT-013
15 Apr 2026 //
GLOBENEWSWIRE
First Patient Dosed in Citryll’s Imaging Study of CIT-013
17 Feb 2026 //
GLOBENEWSWIRE
Citryll Initiates PHASE IIA TRIAL For HIDRADENITIS SUPPURATIVA
08 Dec 2025 //
GLOBENEWSWIRE
Citryll Present CIT-013 Phase I Results In Rheumatoid Arthritis
27 Oct 2025 //
GLOBENEWSWIRE
Citryll Initiates Ph 2A Trial for CIT-013 in Rheumatoid Arthritis
02 Sep 2025 //
GLOBENEWSWIRE
Citryll Forms New Scientific Advisory Board
24 Jul 2025 //
GLOBENEWSWIRE
Citryll Expands CIT-013’s Potential For Treating Inflammatory Disorders
20 Feb 2025 //
GLOBENEWSWIRE
Citryll Gets Grant For NET Research In Rheumatoid Arthritis
03 Oct 2024 //
GLOBENEWSWIRE
CITRYLL Completes Dosing In Phase 1 Trial Of CIT-013
31 Jul 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.